Kuwait Pharmaceuticals and Healthcare Report Q1 2015

BMI Research
January 21, 2015
109 Pages - SKU: BMI5446485
Countries covered: Kuwait

Kuwait Pharmaceuticals and Healthcare Report Q1 2015

BMI View: With some of the largest financial buffers of any GCC member nation, Kuwait is well equippedto insulate health expenditure from the near-term effects of falling oil prices. Accordingly, drugmakers canexpect high and rising underlying demand for branded prescriptions to be well sustained, due to the sector'sperception as a critical source of economic diversification away from hydrocarbons. However, recurrentgovernment resignations and a recent stalemate between the opposition and cabinet, resulting in majordelays to budget approval, illustrate the political volatility created by the deeply dysfunctionalpolicymaking process. As such, we anticipate mounting uncertainty as to the future direction of publicspending, which will increasingly frustrate long-term investment.

Headline Expenditure Projections

Pharmaceuticals: From KWD290mn (USD1.02bn) in 2013 to KWD308mn (USD1.11bn) in 2014;+6.3% in local currency terms and +8.3% in US dollar terms. Forecast up from Q414.

Healthcare: From KWD1.42bn (USD4.99bn) in 2013 to KWD1.53bn (USD5.50bn) in 2014; +8.3% inlocal currency terms and +10.3% in US dollar terms. Forecast unchanged from Q414.



More Prescription Drugs reports by BMI Research

Zimbabwe Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Zimbabwe Pharmaceuticals and Healthcare Report Q2 2015BMI View: Zimbabwe's Treasury has failed to assign sufficient funds to the health sector in its 2015 National Budget, ...
United Kingdom Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
United Kingdom Pharmaceuticals and Healthcare Report Q2 2015BMI View: The ageing population will have an unprecedented impact on the demand of healthcare and therapeutics in ...
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2015BMI View: Access to healthcare in Sudan and South Sudan is poor and drug shortages are ...
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015BMI View: Sri Lanka's strong pharmaceutical market is backed by a committed government and plans to deliver improved ...
See all reports like this >>

More Kuwait Prescription Drugs reports

Pharmaceuticals and Healthcare Report - Kuwait - Q3 2014 by BMI Research
Kuwait Pharmaceuticals and Healthcare Report Q3 2014BMI View: Despite upcoming by-elections, Kuwait's economy is forecast to post moderate growth in 2014,and the prospects for consumption ...
KUWAIT Healthcare & Pharmaceuticals 2013 by Noozz Research
KUWAIT Healthcare & Pharmaceuticals 2013Kuwait’s healthcare and pharmaceutical industries, which are dominated by high levels of government expenditure, and a robust, free public healthcare service ...
See all reports like this >>

More Kuwait reports

D&B Country Report: Kuwait by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!